Navigation path

Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information

Zosuquidar trihydrochloride

EU orphan designation number: EU/3/06/355   
Active ingredient: Zosuquidar trihydrochloride
Indication: Treatment of acute myeloid leukaemia
Sponsor: Kanisa Europe Limited, Mofo Notices Limited, C/Morrison & Foerster MNP
City Point, 1 Ropemaker Street, London EC2Y 9AW, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/02/2006 Orphan designation EMEA/OD/100/05 (2006)559 of 17/02/2006
15/05/2006 Transfer of orphan designation EMEA/OD/100/05/T/01 (2006)1970 of 10/05/2006